Neoadjuvant Twice Daily Chemoradiotherapy for Esophageal Cancer: Treatment-Related Mortality and Long-Term Outcomes

Advances in Radiation Oncology - United States
doi 10.1016/j.adro.2017.05.003
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Open Versus Laparoscopic Surgery for Low Rectal Cancer After Neoadjuvant Chemoradiotherapy: Short-Term Outcomes

Nippon Daicho Komonbyo Gakkai Zasshi
2012English

Lack of Pathological Response of Rectal Cancer to Neoadjuvant Chemoradiotherapy Is Associated With Poorer Long-Term Oncological Outcomes

Clinical Oncology and Research
2019English

Chemoradiotherapy for Esophageal Cancer

The Korean Journal of Helicobacter and Upper Gastrointestinal Research
2019English

Short‑ and Long‑term Outcomes of Definitive Chemoradiotherapy in Patients With Esophageal Carcinoma Aged ≥75�years

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

Neoadjuvant Treatment Strategy for Locally Advanced Thoracic Esophageal Cancer

Annals of Gastroenterological Surgery
2019English

ASO Author Reflections: Intensified Neoadjuvant Chemoradiotherapy Followed by Esophagectomy in Esophageal Cancer

Annals of Surgical Oncology
OncologySurgery
2020English

Long-Term Results of Definitive Concurrent Chemoradiotherapy Using S-1 in the Treatment of Geriatric Patients With Esophageal Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Neoadjuvant Long-Course Chemoradiotherapy for Rectal Cancer: Does Time to Surgery Matter?

International Surgery
Surgery
2015English

Neoadjuvant Chemoradiotherapy in Rectal Cancer

Memo - Magazine of European Medical Oncology
OncologyHematology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy